| Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans health administration study CA Arout, M Sofuoglu, LA Bastian, RA Rosenheck Journal of women's health 27 (8), 1035-1044, 2018 | 98 | 2018 |
| Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations CA Arout, E Edens, IL Petrakis, M Sofuoglu CNS drugs 29 (6), 465-486, 2015 | 95 | 2015 |
| Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor A Juni, M Cai, M Stankova, AR Waxman, C Arout, G Klein, A Dahan, ... The Journal of the American Society of Anesthesiologists 112 (1), 181-188, 2010 | 83 | 2010 |
| Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice AR Waxman, C Arout, M Caldwell, A Dahan, B Kest Neuroscience letters 462 (1), 68-72, 2009 | 68 | 2009 |
| Acute effects of cannabinoids on symptoms of obsessive‐compulsive disorder: A human laboratory study RR Kayser, M Haney, M Raskin, C Arout, HB Simpson Depression and anxiety 37 (8), 801-811, 2020 | 58 | 2020 |
| Morphine-6β-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans ELA Van Dorp, B Kest, WJ Kowalczyk, AM Morariu, AR Waxman, ... The Journal of the American Society of Anesthesiologists 110 (6), 1356-1363, 2009 | 49 | 2009 |
| Spinal and supraspinal N-methyl-D-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia CA Arout, M Caldwell, G Rossi, B Kest Physiology & behavior 147, 364-372, 2015 | 42 | 2015 |
| A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans CA Arout, M Haney, ES Herrmann, G Bedi, ZD Cooper British Journal of Clinical Pharmacology 88 (1), 347-355, 2022 | 41 | 2022 |
| Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients CA Arout, AJ Waters, RR MacLean, P Compton, M Sofuoglu Psychopharmacology 236, 2857-2866, 2019 | 32 | 2019 |
| Morphine induces hyperalgesia without involvement of µ-Opioid receptor or morphine-3-glucuronide M Swartjes, RAG Mooren, AR Waxman, C Arout, K van de Wetering, ... Molecular Medicine 18, 1320-1326, 2012 | 28 | 2012 |
| Effect of intravenous ethanol on capsaicin‐induced hyperalgesia in human subjects CA Arout, AC Perrino Jr, E Ralevski, G Acampora, J Koretski, D Limoncelli, ... Alcoholism: Clinical and Experimental Research 40 (7), 1425-1429, 2016 | 26 | 2016 |
| Rates and correlates of pain specialty clinic use nationally in the Veterans Health Administration CA Arout, M Sofuoglu, RA Rosenheck Pain Medicine 18 (4), 702-710, 2017 | 24 | 2017 |
| Progesterone rapidly recruits female-typical opioid-induced hyperalgesic mechanisms AR Waxman, A Juni, W Kowalczyk, C Arout, WF Sternberg, B Kest Physiology & behavior 101 (5), 759-763, 2010 | 22 | 2010 |
| Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors G Klein, A Juni, CA Arout, AR Waxman, CE Inturrisi, B Kest European journal of pharmacology 586 (1-3), 179-188, 2008 | 21 | 2008 |
| C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration CA Arout, M Caldwell, DP McCloskey, B Kest Physiology & behavior 130, 28-33, 2014 | 19 | 2014 |
| A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence G Klein, A Juni, AR Waxman, CA Arout, CE Inturrisi, B Kest Pharmacology Biochemistry and Behavior 90 (3), 447-452, 2008 | 18 | 2008 |
| Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials M Haney, M Vallée, S Fabre, S Collins Reed, M Zanese, G Campistron, ... Nature Medicine 29 (6), 1487-1499, 2023 | 13 | 2023 |
| 5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers CA Arout, ZD Cooper, SC Reed, RW Foltin, SD Comer, FR Levin, ... Addiction biology 26 (4), e12993, 2021 | 13 | 2021 |
| COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation BF Henry, A Campbell, T Hunt, JK Johnson, AD Mandavia, M Chaple, ... Journal of substance abuse treatment 133, 108550, 2022 | 7 | 2022 |
| Human laboratory models of cannabis use disorder CA Arout, E Herrmann, M Haney Cannabis use disorders, 75-84, 2019 | 6 | 2019 |
